United States - English - NLM (National Library of Medicine)

axia medical solutions, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 50 mg in 1000 mg - acne treatment for the treatment of acne. • have sensitive skin. • are sensitive to benzoyl peroxide. irritation become severe.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 5 g in 100 g - benzoyl peroxide gel 5% and 10% are indicated for use in the topical treatment of mild to moderate acne vulgaris. benzoyl peroxide gel 5% and 10% may be used as an adjunct in acne treatment regimens including antibiotics, retinoic acid products, and sulfur/salicylic acid containing preparations. benzoyl peroxide gel 5% and 10% should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the products.

United States - English - NLM (National Library of Medicine)

cintex services, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 100 mg in 1 g - for the treatment of acne - have very sensitive skin - are sensitive to benzoyl peroxide stop use and ask a doctor if   irritation becomes severe.

United States - English - NLM (National Library of Medicine)

axia medical solutions, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 100 mg in 1 g - acne treatment for the treatment of acne. • have sensitive skin. • are sensitive to benzoyl peroxide. irritation become severe.

United States - English - NLM (National Library of Medicine)

alpha paw inc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide plus+ medicated shampoo for dogs & cats

United States - English - NLM (National Library of Medicine)

harris pharmaceutical, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 50 mg in 1 ml - acne medication - for the treatment of acne

United States - English - NLM (National Library of Medicine)

prugen, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 60 mg - benzepro® foaming cloths are indicated for use in the topical treatment of mild to moderate acne vulgaris. benzepro® foaming cloths should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. discontinue use if hypersensitivity is observed.

United States - English - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm), clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is indicated for the topical treatment of acne vulgaris in patients 12 years or older. clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. [see postmarketing experience (6.2). ] clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. [see warnings and precautions (5.1). ] risk summary there are no available data on clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% use in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcome

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm), clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is indicated for the topical treatment of acne vulgaris in patients 12 years or older. clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. [ see postmarketing experience (6.2). ] clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. [ see warnings and precautions (5.1). ] risk summary there are no available data on clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% use in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or a

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - for the treatment of acne